A5092143437- Lipoproteins and Cardiovascular Health
- Cardiovascular Disease and Adiposity
- Sex and Gender in Healthcare
- Infective Endocarditis Diagnosis and Management
- Systemic Lupus Erythematosus Research
- Cardiovascular Effects of Exercise
- Renal Transplantation Outcomes and Treatments
- Cardiac Arrest and Resuscitation
- Hepatitis C virus research
- Acute Myocardial Infarction Research
- Transplantation: Methods and Outcomes
- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac electrophysiology and arrhythmias
- Heart Failure Treatment and Management
Sorbonne Université
2024-2025
Fondation pour l’innovation en Cadiométabolisme et Nutrition
2025
Assistance Publique – Hôpitaux de Paris
2023-2025
Inserm
2025
Hôpital Bichat-Claude-Bernard
2024
Pitié-Salpêtrière Hospital
2024
Université Paris Cité
2023
Hôpital Cochin
2023
Abstract Background There are currently no data regarding pre-treatment with P2Y12 inhibitors in patients acute myocardial infarction complicated cardiogenic shock (AMI-CS). This study investigates the effectiveness and safety of AMI-CS. Methods Results Using ACTION-SHOCK cohort, we included consecutive hospitalized between 2012 2023 AMI-CS admitted for coronary angiography within 24 hours admission. Pre-treatment was defined by administration before an oral loading dose a inhibitor. We...
Abstract Background Effective management of low-density lipoprotein cholesterol (LDL-C) is crucial for preventing recurrent cardiovascular (CV) events in patients with chronic coronary syndrome (CCS). Sex may impact the LDL-C management, by gender bias and/or sex-specific responses to pharmacological interventions. Purpose We examined CCS patients, assessing target achievement rates and their implications CV outcomes. Methods In international CLARIFY registry, we included 22,134 baseline...
Abstract Background Smoking is a well-identified risk factor for recurrent cardiovascular (CV) events in patients with stable coronary artery disease (CAD). However, smoking status not binary, and there wide diversity of habits trajectories within this population, different consequences on residual CV risk. Purpose To better understand how evolves CAD, it associated subsequent events. Methods We analysed the CLARIFY registry, which included 32,378 CAD. defined groups according to at...
Abstract Background There is currently no specific consensus regarding the screening strategy for CAD in renal transplant candidates. Purposes To describe candidates 1/ Strategies and results of 2/ cardiovascular outcomes this population Methods All patients registered on kidney waiting list our tertiary centre were classified into (unscreened), screened, or with prior CAD. Unscreened was defined as ischemia anatomic testing while within year to listing. Screening considered "positive" when...
We study a case of early obstructive leaflet thrombosis following transcatheter aortic valve replacement (TAVR) in woman her 50s with history Sneddon syndrome treated by antiplatelet therapy. The regressed the use vitamin K antagonists (VKA) for 6 weeks. Subacute TAVR reappeared after discontinuation VKA use. main takeaways this were detection high-risk patients that could benefit from systematic post-TAVR anticoagulation and diagnosis associated elevated transvalvular gradient, whose...